FDA Fraud Medicare Prescription Drug Pricing 
Hall Render
MAY 10, 2024
Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ million expansion ‘Very, very unusual.’
Hall Render
FEBRUARY 18, 2022
13-year Medicare payment dispute will return to HHS, court rules. Meet new FDA chief Dr. Robert Califf: 5 things to know. Only 14% of Hospitals Met Price Transparency Rule Compliance. Florida physician convicted of $110M fraud. A layoff list, expired medicine, neglected patients: Illinois hospital loses Medicare contract.
Drug & Device Law
OCTOBER 10, 2022
The manufacturer sought to cover Medicare patients’ Part D cost-sharing obligations for the drug – which were estimated at approximately $13,000 per year – but the OIG said “no thanks,” and the Second Circuit has affirmed that outcome. That being said, Medicare does not cover the entire cost of the drug. 1320a-7b (“AKS”).
Expert insights. Personalized for you.
40 
Let's personalize your content